Certain Common Stock of Context Therapeutics Inc. are subject to a Lock-Up Agreement Ending on 17-APR-2022. These Common Stock will be under lockup for 180 days starting from 19-OCT-2021 to 17-APR-2022.

Details:
The executive officers and directors and substantially all of the stockholders, have agreed not to, without the prior written consent of the representative, offer, sell, assign, transfer, pledge, contract to sell, or otherwise dispose of or announce the intention to otherwise dispose of, or enter into any swap, hedge or similar agreement or arrangement that transfers, in whole or in part, the economic risk of ownership of, directly or indirectly, engage in any short selling of any common stock or securities convertible into or exchangeable or exercisable for any common stock, whether currently owned or subsequently acquired, for a period of 365 days from the date of this prospectus, in the case of the directors and officers, and 180 days from the date of this prospectus, in the case of the stockholders.